<p>, /PRNewswire/ --</p>
<p>原因：羅森律師事務所是一家全球投資者權益律師事務所，宣佈代表 2025 年 5 月 8 日至 2026 年 3 月 30 日（包括該日期）期間購買 Phreesia, Inc.（紐約證券交易所代碼：PHR）普通股的投資者提起集體訴訟（“集體訴訟期間”）。集體訴訟已被提起。如果您希望擔任首席原告，必須在 2026 年 7 月 13 日之前向法院提出申請。</p>
<p>那麼，如何：如果您在集體訴訟期間購買了 Phreesia 的普通股，您可能有權在不支付任何自付費用或成本的情況下，通過風險收費安排獲得賠償。</p>
<p>接下來該做什麼：要加入 Phreesia 的集體訴訟，請訪問 https://rosenlegal.com/cases/phreesia-inc/join 或撥打無障礙電話 866-767-3653 聯繫 Phillip Kim 律師，或發送電子郵件至 [email protected] 獲取有關集體訴訟的信息。集體訴訟已被提起。如果您希望擔任首席原告，必須在 2026 年 7 月 13 日之前向法院提出申請。首席原告是代表其他集體成員指導訴訟的代表方。</p>
<p>為什麼選擇羅森律師事務所：我們鼓勵投資者選擇在領導角色上有成功記錄的合格律師事務所。通常，發佈通知的公司沒有相應的經驗、資源或任何有意義的同行認可。在選擇律師時要明智。羅森律師事務所代表全球投資者，專注於證券集體訴訟和股東衍生訴訟。羅森律師事務所曾獲得針對中國公司的最大證券集體訴訟和解。該事務所於 2017 年被 ISS 證券集體訴訟服務評選為證券集體訴訟和解數量第一。自 2013 年以來，該事務所每年均排名前四，併為投資者追回了數億美元。僅在 2019 年，該事務所就為投資者爭取了超過 4.38 億美元。在 2020 年，創始合夥人 Laurence Rosen 被 law360 評選為原告律師界的巨頭。該事務所的許多律師已被 Lawdragon 和 Super Lawyers 認可。</p>
<p>案件詳情：根據訴訟，整個集體訴訟期間，被告做出了虛假和/或誤導性的陳述，並/或隱瞞了有關 Phreesia 需求放緩和關鍵收入來源可見性降低的真實不利事實，特別是在其網絡解決方案部門中，製藥市場承諾減弱。當真實情況進入市場時，訴訟聲稱投資者遭受了損失。</p>
<p>要加入 Phreesia 的集體訴訟，請訪問 https://rosenlegal.com/cases/phreesia-inc/join 或撥打無障礙電話 866-767-3653 聯繫 Phillip Kim 律師，或發送電子郵件至 [email protected] 獲取有關集體訴訟的信息。</p>
<p>尚未認證集體。直到集體被認證，您都沒有律師代表，除非您聘請一位。您可以選擇自己喜歡的律師。您也可以保持缺席集體成員身份，此時不採取任何行動。投資者分享任何潛在未來賠償的能力並不依賴於擔任首席原告。</p>
<p>請關注我們的 LinkedIn 更新：https://www.linkedin.com/company/the-rosen-law-firm，Twitter：https://twitter.com/rosen_firm 或 Facebook：https://www.facebook.com/rosenlawfirm/。</p>
<p>律師廣告。之前的結果並不保證類似的結果。</p>
<p>聯繫信息：</p>
<p>Laurence Rosen, Esq.</p>
<p>Phillip Kim, Esq.</p>
<p>羅森律師事務所，P.A.</p>
<p>275 Madison Avenue, 40th Floor</p>
<p>紐約，NY 10016</p>
<p>電話：(212) 686-1060</p>
<p>免費電話：(866) 767-3653</p>
<p>傳真：(212) 202-3827</p>
<p>[email protected]</p>
<p>www.rosenlegal.com</p>
<p>來源：羅森律師事務所，P.A.</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTIwJk5ld3NJdGVtSWQ9REM2NDgzNCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MjAyMTE1UFJfTkVXU19VU1BSX19fX19EQzY0ODM0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTIwJk5ld3NJdGVtSWQ9REM2NDgzNCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MjAyMTE1UFJfTkVXU19VU1BSX19fX19EQzY0ODM0"/></p>

<p>羅森律師事務所已宣佈對在 2025 年 5 月 8 日至 2026 年 3 月 30 日期間購買 Phreesia, Inc.股票的投資者提起集體訴訟。投資者可能有權在沒有前期費用的情況下獲得賠償。必須在 2026 年 7 月 13 日前任命一名首席原告。訴訟指控 Phreesia 誤導投資者關於其需求和收入來源的信息，導致真相浮出水面時造成損失</p>

<p>, /PRNewswire/ --</p>
<div class="lb-trans"><p>, /PRNewswire/ --</p>
</div><p>Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May 8, 2025 and March 30, 2026, inclusive (the &#34;Class Period&#34;). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 13, 2026.</p>
<div class="lb-trans"><p>原因：羅森律師事務所是一家全球投資者權益律師事務所，宣佈代表 2025 年 5 月 8 日至 2026 年 3 月 30 日（包括該日期）期間購買 Phreesia, Inc.（紐約證券交易所代碼：PHR）普通股的投資者提起集體訴訟（“集體訴訟期間”）。集體訴訟已被提起。如果您希望擔任首席原告，必須在 2026 年 7 月 13 日之前向法院提出申請。</p>
</div><p>So what: If you purchased Phreesia common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.</p>
<div class="lb-trans"><p>那麼，如何：如果您在集體訴訟期間購買了 Phreesia 的普通股，您可能有權在不支付任何自付費用或成本的情況下，通過風險收費安排獲得賠償。</p>
</div><p>What to do next: To join the Phreesia class action, go to https://rosenlegal.com/cases/phreesia-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 13, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.</p>
<div class="lb-trans"><p>接下來該做什麼：要加入 Phreesia 的集體訴訟，請訪問 https://rosenlegal.com/cases/phreesia-inc/join 或撥打無障礙電話 866-767-3653 聯繫 Phillip Kim 律師，或發送電子郵件至 [email protected] 獲取有關集體訴訟的信息。集體訴訟已被提起。如果您希望擔任首席原告，必須在 2026 年 7 月 13 日之前向法院提出申請。首席原告是代表其他集體成員指導訴訟的代表方。</p>
</div><p>Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.</p>
<div class="lb-trans"><p>為什麼選擇羅森律師事務所：我們鼓勵投資者選擇在領導角色上有成功記錄的合格律師事務所。通常，發佈通知的公司沒有相應的經驗、資源或任何有意義的同行認可。在選擇律師時要明智。羅森律師事務所代表全球投資者，專注於證券集體訴訟和股東衍生訴訟。羅森律師事務所曾獲得針對中國公司的最大證券集體訴訟和解。該事務所於 2017 年被 ISS 證券集體訴訟服務評選為證券集體訴訟和解數量第一。自 2013 年以來，該事務所每年均排名前四，併為投資者追回了數億美元。僅在 2019 年，該事務所就為投資者爭取了超過 4.38 億美元。在 2020 年，創始合夥人 Laurence Rosen 被 law360 評選為原告律師界的巨頭。該事務所的許多律師已被 Lawdragon 和 Super Lawyers 認可。</p>
</div><p>Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or concealed material adverse facts concerning the true state of Phreesia's slowing demand and reduced visibility in key revenue streams, notably, the weakened pharmaceutical marketing commitments in its Network Solutions segment. When the true details entered the market, the lawsuit claims that investors suffered damages.</p>
<div class="lb-trans"><p>案件詳情：根據訴訟，整個集體訴訟期間，被告做出了虛假和/或誤導性的陳述，並/或隱瞞了有關 Phreesia 需求放緩和關鍵收入來源可見性降低的真實不利事實，特別是在其網絡解決方案部門中，製藥市場承諾減弱。當真實情況進入市場時，訴訟聲稱投資者遭受了損失。</p>
</div><p>To join the Phreesia class action, go to https://rosenlegal.com/cases/phreesia-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.</p>
<div class="lb-trans"><p>要加入 Phreesia 的集體訴訟，請訪問 https://rosenlegal.com/cases/phreesia-inc/join 或撥打無障礙電話 866-767-3653 聯繫 Phillip Kim 律師，或發送電子郵件至 [email protected] 獲取有關集體訴訟的信息。</p>
</div><p>No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.</p>
<div class="lb-trans"><p>尚未認證集體。直到集體被認證，您都沒有律師代表，除非您聘請一位。您可以選擇自己喜歡的律師。您也可以保持缺席集體成員身份，此時不採取任何行動。投資者分享任何潛在未來賠償的能力並不依賴於擔任首席原告。</p>
</div><p>Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.</p>
<div class="lb-trans"><p>請關注我們的 LinkedIn 更新：https://www.linkedin.com/company/the-rosen-law-firm，Twitter：https://twitter.com/rosen_firm 或 Facebook：https://www.facebook.com/rosenlawfirm/。</p>
</div><p>Attorney Advertising. Prior results do not guarantee a similar outcome.</p>
<div class="lb-trans"><p>律師廣告。之前的結果並不保證類似的結果。</p>
</div><p>Contact Information:</p>
<div class="lb-trans"><p>聯繫信息：</p>
</div><p>Laurence Rosen, Esq.</p>
<div class="lb-trans"><p>Laurence Rosen, Esq.</p>
</div><p>Phillip Kim, Esq.</p>
<div class="lb-trans"><p>Phillip Kim, Esq.</p>
</div><p>The Rosen Law Firm, P.A.</p>
<div class="lb-trans"><p>羅森律師事務所，P.A.</p>
</div><p>275 Madison Avenue, 40th Floor</p>
<div class="lb-trans"><p>275 Madison Avenue, 40th Floor</p>
</div><p>New York, NY 10016</p>
<div class="lb-trans"><p>紐約，NY 10016</p>
</div><p>Tel: (212) 686-1060</p>
<div class="lb-trans"><p>電話：(212) 686-1060</p>
</div><p>Toll Free: (866) 767-3653</p>
<div class="lb-trans"><p>免費電話：(866) 767-3653</p>
</div><p>Fax: (212) 202-3827</p>
<div class="lb-trans"><p>傳真：(212) 202-3827</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>www.rosenlegal.com</p>
<div class="lb-trans"><p>www.rosenlegal.com</p>
</div><p>SOURCE THE ROSEN LAW FIRM, P. A.</p>
<div class="lb-trans"><p>來源：羅森律師事務所，P.A.</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTIwJk5ld3NJdGVtSWQ9REM2NDgzNCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MjAyMTE1UFJfTkVXU19VU1BSX19fX19EQzY0ODM0" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC64834&amp;Transmission_Id=202605202115PR_NEWS_USPR_____DC64834&amp;DateId=20260520"/></p>

ETPHR 的投資者有機會主導對 Phreesia, Inc.的證券欺詐訴訟